International Clinical Trial: An investigator-initiated clinical study to evaluate the tolerance, safety and preliminary efficacy of NK cell injection (NC001) in the treatment of advanced solid tumors

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123168) titled 'An investigator-initiated clinical study to evaluate the tolerance, safety and preliminary efficacy of NK cell injection (NC001) in the treatment of advanced solid tumors' on April 22.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Jiangsu Province Hospital

Condition: Advanced solid tumors

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-22

Target Sample Size: Dose Level 1:60;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=300593

Published by HT Digital Content Services with permission from H...